{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:14:17Z","timestamp":1672848857987},"reference-count":30,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1507\/endocrj.ej13-0389","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:04:57Z","timestamp":1385597097000},"page":"177-183","source":"Crossref","is-referenced-by-count":2,"title":["Abdominal obesity validates the association between elevated alanine aminotransferase and newly diagnosed diabetes mellitus"],"prefix":"10.1507","volume":"61","author":[{"given":"Chen-Yu","family":"Yueh","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan"},{"name":"Chang Gung University of Science and Technology, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Hsu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan"},{"name":"Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ting","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Wen","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Chang Gung Memorial Hospital, Chiayi, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gregg EW, Cadwell BL, Cheng YJ, Cowie CC, Williams DE et al. (2004) Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. <i>Diabetes Care <\/i>27(12): 2806-2812.","DOI":"10.2337\/diacare.27.12.2806"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lauruschkat AH, Arnrich B, Albert AA, Walter JA, Amann B et al. (2005) Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. <i>Circulation <\/i>112(16): 2397-2402.","DOI":"10.1161\/CIRCULATIONAHA.105.534545"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Danaei G, Friedman AB, Oza S, Murray CJ, Ezzati M (2009) Diabetes prevalence and diagnosis in US states: analysis of health surveys. <i>Popul Health Metr <\/i>7: 16.","DOI":"10.1186\/1478-7954-7-16"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cosson E, Hamo-Tchatchouang E, Banu I, Nguyen MT, Chiheb S et al. (2010) A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and\/or HbA1c are measured in overweight or obese patients. <i>Diabetes Metab <\/i>36(4): 312-318.","DOI":"10.1016\/j.diabet.2010.02.004"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R et al. (2003) Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. <i>Circulation <\/i>108(4): 420-425.","DOI":"10.1161\/01.CIR.0000080884.27358.49"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR et al. (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. <i>Arch Intern Med <\/i>163(4): 427-436.","DOI":"10.1001\/archinte.163.4.427"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K et al. (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. <i>Arch Intern Med <\/i>164(10): 1066-1076.","DOI":"10.1001\/archinte.164.10.1066"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gomez-Samano MA, Gulias-Herrero A, Cuevas-Ramos D, Brau-Figueroa H, Mehta R et al. (2012) Metformin and improvement of the hepatic insulin resistance index independent of anthropometric changes. <i>Endocr Pract <\/i>18(1): 8-16.","DOI":"10.4158\/EP11072.OR"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. <i>N Engl J Med <\/i>344(18): 1343-1350.","DOI":"10.1056\/NEJM200105033441801"},{"key":"10","unstructured":"10. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. <i>N Engl<\/i><i> J Med <\/i>346(6): 393-403."},{"key":"11","unstructured":"11. Ohlson LO, Larsson B, Bjorntorp P, Eriksson H, Svardsudd K et al. (1988) Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. <i>Diabetologia <\/i>31(11): 798-805."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE et al. (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. <i>Diabetes <\/i>51(6): 1889-1895.","DOI":"10.2337\/diabetes.51.6.1889"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sattar N, Scherbakova O, Ford I, O&rsquo;Reilly DS, Stanley A et al. (2004) Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. <i>Diabetes <\/i>53(11): 2855-2860.","DOI":"10.2337\/diabetes.53.11.2855"},{"key":"14","unstructured":"14. Hanley AJ, Wagenknecht LE, Festa A, D&rsquo;Agostino RB, Jr., Haffner SM (2007) Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. <i>Diabetes Care <\/i>30(7): 1819-1827."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bonnet F, Ducluzeau PH, Gastaldelli A, Laville M, Anderwald CH et al. (2011) Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. <i>Diabetes <\/i>60(6): 1660-1667.","DOI":"10.2337\/db10-1806"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M et al. (2007) Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. <i>Obesity (Silver Spring) <\/i>15(7): 1841-1850.","DOI":"10.1038\/oby.2007.218"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Perry IJ, Wannamethee SG, Shaper AG (1998) Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. <i>Diabetes Care <\/i>21(5): 732-737.","DOI":"10.2337\/diacare.21.5.732"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chen PH, Chen JD, Lin YC (2009) A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase. <i>World J Gastroenterol <\/i>15(44): 5598-5603.","DOI":"10.3748\/wjg.15.5598"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yueh CY, Chen JH, Lee LW, Lu CW, Parekh B et al. (2011) Elevated alanine aminotransferase is associated with metabolic syndrome but not consistently associated with impaired fasting glucose or type 2 diabetes mellitus. <i>Diabetes Res Clin Pract <\/i>94(1): 64-70.","DOI":"10.1016\/j.diabres.2011.05.038"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. <i>Circulation <\/i>112(17): 2735-2752.","DOI":"10.1161\/CIRCULATIONAHA.105.169404"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Erbey JR, Silberman C, Lydick E (2000) Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes. <i>Am J Med <\/i>109(7): 588-590.","DOI":"10.1016\/S0002-9343(00)00602-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS et al. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob\/ob mice. <i>Mol Cell <\/i>6(1): 77-86.","DOI":"10.1016\/S1097-2765(05)00010-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. <i>Hepatology <\/i>37(5): 1202-1219.","DOI":"10.1053\/jhep.2003.50193"},{"key":"24","unstructured":"24. O&rsquo;Brien RM, Granner DK (1991) Regulation of gene expression by insulin. <i>Biochem J <\/i>278 (Pt 3): 609-619."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Salmela PI, Sotaniemi EA, Niemi M, Maentausta O (1984) Liver function tests in diabetic patients. <i>Diabetes Care <\/i>7(3): 248-254.","DOI":"10.2337\/diacare.7.3.248"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Skelly MM, James PD, Ryder SD (2001) Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. <i>J Hepatol <\/i>35(2): 195-199.","DOI":"10.1016\/S0168-8278(01)00094-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. West J, Brousil J, Gazis A, Jackson L, Mansell P et al. (2006) Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus. <i>QJM <\/i>99(12): 871-876.","DOI":"10.1093\/qjmed\/hcl116"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. <i>Am J Gastroenterol <\/i>98(5): 960-967.","DOI":"10.1111\/j.1572-0241.2003.07486.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC et al. (2007) Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. <i>J Gastroenterol Hepatol <\/i>22(9): 1482-1489.","DOI":"10.1111\/j.1440-1746.2006.04615.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gomez-Samano MA, Cuevas-Ramos D, Mehta R, Brau-Figueroa H, Meza-Arana CE et al. (2012) Association of Alanine Aminotransferase Levels (ALT) with the Hepatic Insulin Resistance Index (HIRI): a cross-sectional study. <i>BMC Endocr Disord <\/i>12(1): 16.","DOI":"10.1186\/1472-6823-12-16"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/2\/61_EJ13-0389\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:40:09Z","timestamp":1618296009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/2\/61_EJ13-0389\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej13-0389","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}